SCHEMBL3094635

SCHEMBL3094635

CCC(C)C(CC)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12512567 1.00
SCHEMBL13398730 0.90
SCHEMBL4383831 0.90
SCHEMBL1613788 0.88
SCHEMBL1027870 0.84
SCHEMBL597793 0.83
SCHEMBL19158064 0.83
SCHEMBL2483308 0.80 LMNA (0.46)
SCHEMBL7247072 0.80 LMNA (0.41)
SCHEMBL4946041 0.80 LMNA (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220098468-A1 USE OF ESTERAMINE TO INHIBIT THE AGGLOMERATION OF GAS HYDRATES ARKEMA FRANCE (FR) 2022-03-31 US disclosed
EP-3921384-A1 USE OF ESTERAMINE FOR PREVENTING THE AGGLOMERATION OF GAS HYDRATES ARKEMA FRANCE (FR) 2021-12-15 EP disclosed
EP-3372581-B1 FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL DAIKIN IND LTD (JP) 2021-06-23 EP disclosed
US-10894770-B2 Fullerene derivative and n-type semiconductor material DAIKIN INDUSTRIES, LTD. (JP) 2021-01-19 US disclosed
WO-2020161408-A1 USE OF ESTERAMINE FOR PREVENTING THE AGGLOMERATION OF GAS HYDRATES ARKEMA FRANCE (FR) 2020-08-13 WO disclosed
WO-2020161407-A1 COMPOSITION FOR PREVENTING AGGLOMERATION OF GAS HYDRATES ARKEMA FRANCE (FR) 2020-08-13 WO disclosed
US-20180282274-A1 FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL DAIKIN INDUSTRIES, LTD. (JP) 2018-10-04 US disclosed
EP-3372581-A1 FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL Daikin Industries, Ltd. (JP) 2018-09-12 EP disclosed
WO-2017060349-A1 HOLLOW WAX CAPSULES WITH REDUCED CARBON DIOXIDE RELEASE FOR ATTRACTING SOIL-DWELLING PESTS BASF SE (DE) 2017-04-13 WO disclosed
US-20150044161-A1 MULTIFUNCTIONAL POLYMERS ISP INVESTMENTS INC. (US) 2015-02-12 US disclosed
US-5597846-A ESTERS OF RADICICOL SANKYO COMPANY, LIMITED (JP) 1997-01-28 US disclosed
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
WO-1991018905-A1 RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY SANKYO COMPANY LIMITED (JP) 1991-12-12 WO disclosed
EP-0460950-A1 Radicicol derivatives, their preparation and their anti-tumour activity Sankyo Company Limited (JP) 1991-12-11 EP disclosed
EP-0395446-A2 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists Sankyo Company Limited (JP) 1990-10-31 EP disclosed
EP-0038507-A1 Process for the manufacture of carboxylic acid nitriles Ruhrchemie Aktiengesellschaft (DE) 1981-10-28 EP disclosed